Chin A, Nguma J, Ahmad M
J Assist Reprod Genet. 2024; 41(7):1727-1731.
PMID: 38695986
PMC: 11263300.
DOI: 10.1007/s10815-024-03125-6.
Han Y, Fan L, Xue Y
Comput Struct Biotechnol J. 2024; 24:306-313.
PMID: 38681134
PMC: 11052690.
DOI: 10.1016/j.csbj.2024.04.027.
Qasim N, Zhumagaliuly A, Khozhamkul R, Rahim F
J Genet Eng Biotechnol. 2024; 22(1):100340.
PMID: 38494256
PMC: 10980863.
DOI: 10.1016/j.jgeb.2023.100340.
Liao B, Ma Y, Lei R
Front Pharmacol. 2023; 14:1214590.
PMID: 37701030
PMC: 10494434.
DOI: 10.3389/fphar.2023.1214590.
Sinclair F, Begum A, Dai C, Toth I, Moyle P
Drug Deliv Transl Res. 2023; 13(5):1500-1519.
PMID: 36988873
PMC: 10052255.
DOI: 10.1007/s13346-023-01320-z.
Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations.
Bhattacharya S, Satpati P
ACS Omega. 2023; 8(2):1817-1837.
PMID: 36687047
PMC: 9850488.
DOI: 10.1021/acsomega.2c05583.
Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.
Xue Y, Shang L
Front Bioeng Biotechnol. 2022; 10:939295.
PMID: 35860327
PMC: 9289183.
DOI: 10.3389/fbioe.2022.939295.
Governance of Heritable Human Gene Editing World-Wide and Beyond.
Xue Y, Shang L
Int J Environ Res Public Health. 2022; 19(11).
PMID: 35682323
PMC: 9180052.
DOI: 10.3390/ijerph19116739.
CRISPR-Cas9 and He Jiankui's Case: an Islamic Bioethics Review using and .
Alsomali N, Hussein G
Asian Bioeth Rev. 2021; 13(2):149-165.
PMID: 34394752
PMC: 8298734.
DOI: 10.1007/s41649-021-00167-1.
Regulating reproductive genetic services: dealing with spiral-shaped processes and techno-scientific imaginaries.
Alon I, Urbanos-Garrido R, Guimon J
J Assist Reprod Genet. 2021; 38(2):305-317.
PMID: 33405005
PMC: 7884509.
DOI: 10.1007/s10815-020-02017-9.
Identifiability, Risk, and Information Credibility in Discussions on Moral/Ethical Violation Topics on Chinese Social Networking Sites.
Chen X, Huang C, Cheng Y
Front Psychol. 2020; 11:535605.
PMID: 33192777
PMC: 7644537.
DOI: 10.3389/fpsyg.2020.535605.
Responsible Translational Pathways for Germline Gene Editing?.
Cwik B
Curr Stem Cell Rep. 2020; 6(4):126-133.
PMID: 32844082
PMC: 7441015.
DOI: 10.1007/s40778-020-00179-x.
Informed Consent for Human Embryo Genome Editing.
Jonlin E
Stem Cell Reports. 2020; 14(4):530-537.
PMID: 32294411
PMC: 7160388.
DOI: 10.1016/j.stemcr.2020.03.010.
Germline Genome Editing Research: What Are Gamete Donors (Not) Informed About in Consent Forms?.
Niemiec E, Howard H
CRISPR J. 2020; 3(1):52-63.
PMID: 32091253
PMC: 7047087.
DOI: 10.1089/crispr.2019.0043.
Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?.
Kalidasan V, Das K
Front Microbiol. 2020; 11:46.
PMID: 32082282
PMC: 7005723.
DOI: 10.3389/fmicb.2020.00046.
The technical risks of human gene editing.
Davies B
Hum Reprod. 2019; 34(11):2104-2111.
PMID: 31696232
PMC: 6913216.
DOI: 10.1093/humrep/dez162.
The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy.
Sanches-da-Silva G, Medeiros L, Lima F
Int J Genomics. 2019; 2019:8458263.
PMID: 31531340
PMC: 6721108.
DOI: 10.1155/2019/8458263.
Canada's Pragmatic Reforms in Support of Research.
Bubela T, Kleiderman E, Master Z, Ogbogu U, Ravitsky V, Zarzeczny A
Front Med (Lausanne). 2019; 6:157.
PMID: 31355201
PMC: 6636215.
DOI: 10.3389/fmed.2019.00157.
Fostering a prevention mindset for responsible gene editing.
Meagher K, Master Z
Account Res. 2019; 26(4):251-256.
PMID: 31074637
PMC: 6545880.
DOI: 10.1080/08989621.2019.1617140.
Getting serious about the challenge of regulating germline gene therapy.
Caplan A
PLoS Biol. 2019; 17(4):e3000223.
PMID: 31039143
PMC: 6490874.
DOI: 10.1371/journal.pbio.3000223.
